Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Search results for: inflammation

Biologic Logic: Making Sense of Current Therapies for Rheumatic Diseases

  |  

Continuing the ARHP 2009 Audioconference/Webcast series, Daniel F. Battafarano, DO, FACP, FACR, will discuss the use of biologic therapy in the treatment of rheumatology patients on February 10 from noon to 1:00 pm ET. During the session, Dr. Battafarano will review basic immunology, inflammation, and relevant cytokines for common rheumatic diseases. In addition, he will describe the current biologic therapies and their relationship to rheumatic disease outcomes, and identify future biologic strategies for therapy.

Systemic Lupus Erythematosus

  |  

Systemic lupus erythematosus, often called SLE or lupus, is a chronic inflammatory disease that can affect the skin, joints, kidneys, lungs, nervous system, and other organs of the body. It is sometimes labeled the “great imitator” because its wide variety of symptoms can often be confused with other disorders. Usually, patients with SLE experience skin rashes and arthritis as well as fatigue and fever, and the disease can be fatal. However, improvements in therapy have significantly increased these patients’ quality of life and their life expectancy.

Patient Fact Sheet: Rheumatoid Arthritis

  |  

Rheumatoid arthritis (RA), the most common form of inflammatory arthritis, is a chronic disease that causes pain, stiffness, swelling, and limitation in the motion and function of multiple joints. RA is classified as an autoimmune disease, which develops because certain cells of the immune system malfunction and attack healthy joints.